Edwards Lifesciences EW Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.09B+2.3% | $1.07B-21.5% | $1.36B-67.1% | $4.14B-0.8% | $4.18B+0.1% | ||
| $160.9M+2.7% | $156.6M+0.1% | $156.5M+3.1% | $151.8M-1.0% | $153.3M-1.2% | ||
| $163.3M+3.3% | $158.1M+5.0% | $150.6M-0.6% | $151.5M-4.1% | $157.9M-2.7% | ||
| $1.36B-14.8% | $1.6B— | —— | —— | —— | ||
| $269.1M+3.4% | $260.2M+22.4% | $212.6M+2.7% | $207M-14.8% | $243.1M-3.7% | ||
| $71.1M+9.7% | $64.8M-16.1% | $77.2M-24.8% | $102.6M— | —— | ||
| -$891M-25.0% | -$712.9M— | —— | —— | —— | ||
| $1.06B+18.3% | $893.4M-6.2% | $952.9M-24.7% | $1.27B-10.8% | $1.42B+22.3% | ||
| -$1.2B-19.1% | -$1.01B-1.1% | -$998.1M+19.2% | -$1.23B+7.3% | -$1.33B-31.6% | ||
| —— | —— | —— | —— | —— | ||
| $1.09B-18.4% | $1.34B— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Edwards Lifesciences generate?
- Edwards Lifesciences (EW) generated $1.4B in operating cash flow over the trailing twelve months.
- What is Edwards Lifesciences's free cash flow?
- After $269.1M of capital expenditures, Edwards Lifesciences's free cash flow was $1.1B over the trailing twelve months, up 57.5% year over year.
- Where does Edwards Lifesciences's cash flow data come from?
- Every line is extracted from Edwards Lifesciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
